Thursday
SESSION XVII: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2009 (5-MINUTE TALKS)
Moderators:Caron B. Rockman, MD / Anatoly V. Pokrovsky, MD
SESSION XVII SCHEDULE
2:28 PM - 2:33 PM Debate 10: CAS Is Dead Based On Population Based Studies And Level I Evidence
  Presenters(s):Jean-Pierre Becquemin, MD, FRCS  
2:34 PM - 2:39 PM Debate 10: CAS Is Not Dead: It Will Have A Role In Symptomatic Patients When Used With New And Better Technology (Better Stents/Flow Reversal) And Better Patient Selection
  Presenters(s):Marc Bosiers, MD  
2:40 PM - 2:45 PM Anatomic And Lesion Characteristics Are Accurate Predictors Of Stroke From CAS: What Technique Is Best For Determining This?
  Presenters(s):Mark H. Wholey, MD  
2:46 PM - 2:51 PM New Key Information From The SPACE Trial: Cerebral Protection vs. No Cerebral Protection: Timing Of Strokes With CAS; Incidence Of Restenosis After CAS And CEA; Open vs. Closed Stents – Which Is Best?
  Presenters(s):Hans-Henning Eckstein, MD, PhD / Olav Jansen, MD  
2:52 PM - 2:58 PM Results Of The ICSS Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic Patients
  Presenters(s):Frans L. Moll, MD, PhD  
2:59 PM - 3:04 PM 1-Year Results Of The CREST Trial: Randomized Comparison Of CAS vs. CEA In Symptomatic And Asymptomatic Patients
  Presenters(s):Wesley S. Moore, MD  
3:05 PM - 3:10 PM Where Do We Go From Here With Randomized Trials Of CAS vs. CEA: Do We Need More Trials In Asymptomatic Patients With A Best Medical Treatment Arm; More Trials With Better Patient Selection; Or More Trials With Better Technology For CAS (Flow Reversal and Better Stent Systems)?
  Presenters(s):Thomas Brott, MD  
3:11 PM - 3:16 PM CAS With Proximal Protection (Flow Cessation/Reversal) And Hybrid (Cristallo) Stents: Will This Be A Better And Universally Safe Approach?
  Presenters(s):Giancarlo Biamino, MD, PhD / Alberto Cremonesi, MD, FESC  
3:17 PM - 3:22 PM Debate 11: Indirect Markers Of Cerebral Embolization (TCD and Diffusion-Weighted MRI) Are Of Great Value In Differentiating Strategies For Embolic Protection In CAS
  Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
3:23 PM - 3:28 PM Debate 11: Indirect Markers Of Cerebral Embolization (TCD and DW-MRI) Are Of Little Value In Differentiating Strategies For Embolic Protection In CAS Because Most Strokes With CAS Occur Before Or After Embolic Protection Devices Are Functioning
  Presenters(s):Emmanuel M. Houdart, MD  
3:29 PM - 3:34 PM Imaging Suite Of The Future Will Combine Many Modalities: What Can Be Combined With Fluoroscopy To Facilitate Endovascular Procedures?
  Presenters(s):Michael D. Dake, MD  
3:35 PM - 3:40 PM Panel Discussion
Moderator(s): Mark H. Wholey, MD / Anatoly V. Pokrovsky, MD / Frank J. Veith, MD  
3:40 PM - 3:45 PM Debate 12: Medical Treatment Is Best For Most Asymptomatic Patients With Carotid Stenosis
  Presenters(s):Peter R.F. Bell, MD, FRCS, DSC, KBE  
3:46 PM - 3:51 PM Debate 12: CEA Or CAS, Not Medical Treatment, Is Best For Most Asymptomatic Patients With >60% Carotid Stenosis
  Presenters(s):Peter A. Schneider, MD  
3:52 PM - 3:57 PM Interventional Treatment (CAS or CEA) Should Await New Diagnostic Methods: What Is On The Horizon?
  Presenters(s):Henrik Sillesen, MD, DMSc  
3:58 PM - 4:03 PM Best Medical Treatment Is Currently The Optimal Management For >60% Carotid Stenosis In Asymptomatic Patients: What Is Needed To Maximize The Benefit Of CAS In Such Patients?
  Presenters(s):Michael R. Jaff, DO  
4:04 PM - 4:09 PM Value Of Intense Lipid Lowering Treatment In Patients With Asymptomatic Carotid Stenosis
  Presenters(s):J. David Spence, MD  
4:10 PM - 4:15 PM How To Identify Vulnerable Carotid Plaques In Asymptomatic Patients Noninvasively With Molecular Imaging
  Presenters(s):Clark J. Zeebregts, MD, PhD  
4:16 PM - 4:21 PM How To Predict Which Asymptomatic Patients Are At High Risk For Stroke So They Can Be Treated Invasively Without Treating All Asymptomatic Patients: Present Status And Future Possibilities
  Presenters(s):Giorgio M. Biasi, MD  
4:22 PM - 4:27 PM Effect Of Exercise And Statins On Carotid Plaques: Implications For Invasive Treatment Of Asymptomatic Patients
  Presenters(s):Christos D. Liapis, MD  
4:28 PM - 4:33 PM Status Of The TACIT Trial: Will We Ever Know The Truth About How Asymptomatic Patients With Carotid Stenosis Should Be Treated?: Will The Stimulus Package Save The Day For TACIT?
  Presenters(s):John H. Rundback, MD, FSIR, FAHA  
4:34 PM - 4:39 PM Panel Discussion
END OF SESSION XVII
previous next